Varian Medical Systems's ProBeam Proton Therapy System FDA Approved

share Share
Varian Medical Systems of Palo Alto, California, the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery and brachytherapy, has received US FDA 510(k) clearance for its updated ProBeam proton therapy system.

Varian's ProBeam system gives clinicians options for delivering dose precisely in order to minimise dose to healthy tissue in the course of delivering proton therapy treatments for cancer. 

Its scanning beam technology enables intensity-modulated proton therapy (IMPT) by modulating dose levels on a spot-by-spot basis throughout the treatment area. Irradiations from multiple angles are combined in an optimal manner to improve control of dose distributions. Scanning beam technology also eliminates the time-consuming need to manually insert separate shaping accessories for each beam angle in order to match the beam to the shape of the tumor.

Varian's scanning beam IMPT technology is already at work in the Rinecker Proton Therapy Center in Germany, which has now treated over 1,500 patients. 

Varian also has contracts to install ProBeam systems at six sites: four in the United States, one in Saudi Arabia, and one in Russia.


21 January 2014

Published on : Wed, 22 Jan 2014


Print as PDF

Related Articles

Philips and Russia’s largest network of private clinics sign MOU for strategic partnershipRoyal Philips and MEDSI, Russia’s largest... Read more

Cancer Myths: Why it’s Crucial to Debunk ThemWith one third of all cancer cases being potentially preventable, it’s very important... Read more

Currently being developed by University of Washington scientists and engineers, a novel, credit-card sized, low cost device could... Read more

Cancer, Radiotherapy, Dose, Technology, Varian, intensity-modulated proton therapy, IMPT Varian Medical Systems of Palo Alto, California, the world's leading manufacturer of medical devices and software for treating cancer and other medica

No comment


Please login to leave a comment...

Highlighted Products